NEW YORK – Telegenomics firm Genome Medical said Wednesday that it has raised $14 million in an extended Series B financing round, adding to the $23 million it raised in the Series B financing last year.
The San Francisco-headquartered company plans to use the funds to improve patient engagement and navigation within its Genome Care Delivery technology platform, so that more patients in the US have access to genomic medicine for cancer, reproductive health, and pharmacogenetics.